Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
There was no correlation between serum sclerostin and iPTH, hs-CRP, 25(OH) vitamin D, and alkaline phosphatase (Table 1).
Source: Relationships between serum sclerostin level and renal function and bone and mineral metabolism. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
A total of 140 patients with CKD 3 to 5ND were enrolled in this cross-sectional study.
Source: Abstract.
A total of 140 patients aged ≥ 18 years with CKD 3 to 5ND were enrolled in the study between February 2015 and October 2016.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
The relationship between sclerostin and carotid artery atherosclerosis in patients with stage 3 to 5 chronic kidney disease
Cross-sectional study · International Urology and Nephrology · 2020
Original publication title
The relationship between sclerostin and carotid artery atherosclerosis in patients with stage 3 to 5 chronic kidney disease
© The Author(s) 2020
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Sclerostin is an antagonist of the Wnt/β-catenin pathway. We previously reported that sclerostin is closely related to carotid artery atherosclerosis and long-term outcome in hemodialysis patients. The present study investigated the association between sclerostin, renal function, and carotid artery atherosclerosis in non-dialysis patients with stage 3 to 5 chronic kidney disease (CKD 3 to 5ND).
Source: PurposeAbstract: What methods does the paper describe?
A total of 140 patients with CKD 3 to 5ND were enrolled in this cross-sectional study. The Chronic Kidney Disease Epidemiology Collaboration equation was used to calculate estimated glomerular filtration rate (eGFR). Atherosclerotic plaques in the carotid artery were detected by B-mode Doppler ultrasound. Blood samples were collected to assess serum sclerostin levels. Unconditional logistic regression analysis was used to identify risk factors for carotid atherosclerotic plaques.
Source: MethodsAbstract: Electronic supplementary material
The online version of this article (10.1007/s11255-020-02495-x) contains supplementary material, which is available to authorized users.
Source: Electronic supplementary materialAbstract: Results
The median eGFR was 24.9 ml/min/1.73 m2 (interquartile range [IQR] 10.0 to 40.3 ml/min/1.73 m2) and median serum sclerostin level was 46.76 pmol/l (IQR 30.18 to 67.56 pmol/l). Carotid atherosclerotic plaques were detected in 104 subjects (74.3%). There was a negative association between sclerostin level and eGFR (r = − 0.214, p = 0.011). Unconditional logistic regression analysis revealed that sclerostin level was an independent risk factor for the occurrence of carotid plaques, with an odds ratio (95% confidence interval) of 1.026 (1.003, 1.051).
Source: ResultsAbstract: Conclusion
Serum sclerostin increases with declining renal function in patients with CKD 3 to 5ND. Sclerostin is an independent risk factor for carotid atherosclerosis.
Source: ConclusionAuthors’ abstract
Purpose
Sclerostin is an antagonist of the Wnt/β-catenin pathway. We previously reported that sclerostin is closely related to carotid artery atherosclerosis and long-term outcome in hemodialysis patients. The present study investigated the association between sclerostin, renal function, and carotid artery atherosclerosis in non-dialysis patients with stage 3 to 5 chronic kidney disease (CKD 3 to 5ND).
Methods
A total of 140 patients with CKD 3 to 5ND were enrolled in this cross-sectional study. The Chronic Kidney Disease Epidemiology Collaboration equation was used to calculate estimated glomerular filtration rate (eGFR). Atherosclerotic plaques in the carotid artery were detected by B-mode Doppler ultrasound. Blood samples were collected to assess serum sclerostin levels. Unconditional logistic regression analysis was used to identify risk factors for carotid atherosclerotic plaques.
Results
The median eGFR was 24.9 ml/min/1.73 m2 (interquartile range [IQR] 10.0 to 40.3 ml/min/1.73 m2) and median serum sclerostin level was 46.76 pmol/l (IQR 30.18 to 67.56 pmol/l). Carotid atherosclerotic plaques were detected in 104 subjects (74.3%). There was a negative association between sclerostin level and eGFR (r = − 0.214, p = 0.011). Unconditional logistic regression analysis revealed that sclerostin level was an independent risk factor for the occurrence of carotid plaques, with an odds ratio (95% confidence interval) of 1.026 (1.003, 1.051).
Conclusion
Serum sclerostin increases with declining renal function in patients with CKD 3 to 5ND. Sclerostin is an independent risk factor for carotid atherosclerosis.
Electronic supplementary material
The online version of this article (10.1007/s11255-020-02495-x) contains supplementary material, which is available to authorized users.
Publication and source details
Original title: The relationship between sclerostin and carotid artery atherosclerosis in patients with stage 3 to 5 chronic kidney disease
Ban Zhao; Aiqun Chen; Haitao Wang; Ju Cui; Ying Sun; Lengnan Xu; Yonghui Mao
International Urology and Nephrology · 2020
© The Author(s) 2020https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.http://dx.doi.org/10.13039/501100002855Ministry of Science and Technology of the People's Republic of China2017ZX09304026Mao YonghuiRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T17:41:02.143895+00:00
DOI: 10.1007/s11255-020-02495-x · PMC7314717